Healthcare technology company Aktiia has received FDA 510(k) clearance for its over-the-counter cuffless blood pressure ...

Aktiia, a pioneer in continuous blood pressure monitoring, has secured FDA 510(k) clearance for its medical-grade G0 Blood ...

Aktiia, a pioneer in optical blood pressure monitoring, announced today that it has received U.S. Food and Drug ...

Neuchâtel, Switzerland-based Aktiia said its G0 Blood Pressure Monitoring System will be available in the U.S. in 2026.

The band can be worn during the day and night, allowing patients to track blood pressure patterns across a 24-hour cycle.

Aktiia claims its app can give users accurate blood pressure and heart rate measurements from the camera of a smartphone. Users place their fingertip on the camera, and in 90 seconds the software ...

Aktiia has already been the subject of European clinical trials, and will soon be assessed in an American trial to be conducted in partnership with Harvard-affiliated Brigham and Women's Hospital.

The Aktiia app would leverage something everyone has – a smartphone. And that makes it more powerful than even having blood pressure tracking on ubiquitous smartwatches such as the Apple Watch.

Aktiia, a health tech startup transforming hypertension care, has announced promising results from a preliminary study comparing their cuff-less and continual blood pressure monitor with ...

Aktiia costs £199 (around $250) and is going on sale in the UK now, before rolling out to more territories. There’s also a £8.99 (~$10) per month subscription after the first year.

The FDA has cleared its first cuffless blood pressure monitor that will be available over-the-counter, with the Hilo ...

Aktiia (based out of Neuchatel, Switzerland, but with a U.S. operation) already specialized in blood pressure technology with a hardware sensor that sits at your wrist. However, it’s now ...